Plasma beta-endorphin concentrations in people with learning disability and self-injurious and/or autistic behaviour

British Journal of Psychiatry

Volumn 168, Issue JAN., 1996, Pages 105-109

  Willemsen Swinkels, Sophie H N ^a   Buitelaar, Jan K ^a,c   Weijnen, Florence G ^a   Thijssen, Jos H H ^b   Van Engeland, Herman ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Dept of Child and Adol Psychiatry ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN;

ADULT; ARTICLE; AUTISM; AUTOMUTILATION; BLOOD ANALYSIS; CLINICAL ARTICLE; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; LEARNING DISORDER; MALE; PROTEIN DETERMINATION;

EID: 0029994439     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.168.1.105     Document Type: Article

References (18)

1. AMAN, M. G., SINGH, N. N., STEWART, A. W., et al (1985) The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485-491.
2. AMERICAN PSYCHIATRIC ASSOCIATION (1987) The Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.
3. BUITELAAR, J. K. (1993) Self-injurious behavior in retarded children: clinical phenomena and biological mechanisms. Acta Paedopsychiatrica, 56, 105-111.
4. DEUTSCH, S. I. (1986) Rationale for the administration of opiate antagonists in treating infantile autism. American Journal of Mental Deficiency, 90, 631-635.
5. ERNST, M., DEVI, L., SILVA, R. R., et al (1993) Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. Psychopharmacology Bulletin, 19, 221-227.
6. GILLBERG, C, TERENIUS, L., HAOBERG, B., et al (1990) CSF beta-endorphins in childhood neuropsychiatric disorders. Brain and Development, 12, 88-92.
7. GISPEN-DE WIED, C. C., WESTERBERG, H. G. M. & THIJSSEN, J. H. H. (1987) The dexamethasone and cortisol suppression test in depression: β-endorphin as a useful marker. Psychoneuroendocrinology, 12, 355-366.
8. HERMAN, B. H. (1990) A possible role of proopiomelano-cortin peptides in self-injurious behavior. Progress in Neuro-psychopharmacology and Biological Psychiatry, 14, S109-S139.
9. _, HAMMOCK, M. K., ARTHUR-SMITH, A., et al (1986) Role of opioid peptides in autism: effects of acute administration of naltrexone. Society for Neuroscience Abstracts, 12, 1172.
10. _, _, EGAN, J., et al (1989) Role for opioid peptides in self-injurious behavior; Dissociation from autonomic nervous system functioning. Developmental Pharmacology and Therapeutics, 12, 81-89.
11. KRAIJER, D. W. (1990) Autisme- en verwante kontaktstoornis-senschaal voor zwakzinnigen. Handleiding A.V.Z. Lisse: Swets & Zeitungen B.V.
12. LEBOYER, M., BOUVARD, M. P., RECASENS, C., et al (1994) Difference between plasma N- and C-terminally directed β-endorphin immunoreactivity in infantile autism. American Journal of Psychiatry, 151, 1797-1801.
13. PANKSEPP, J. & SAHLEY, T. L. (1987) Possible brain opioid involvement in disrupted social intent and language development of autism. In Neurobiological Issues in Autism (eds E. Schopler & G. B. Mesibov), pp. 357-372. New York: Plenum Press.
14. ROSS, D. L., KLYKYLO, W. M., HITZEMANN, R. (1987) Reduction of elevated CSF beta-endorphin by fenfluramine in infantile autism. Pediatric Neurology, 3, 83-86.
15. SANDMAN, C. A., BARRON, J. L., CHICZ-DEMET, A., et al (1990) Plasma β-endorphin levels in patients with self-injurious behavior and stereotypy. American Journal on Mental Retardation, 95, 84-92.
16. _, _, _, et al (1991) Brief report: plasma β-endorphin and cortisol levels in autistic patients. Journal of Autism and Developmental Disorders, 21, 83-87.
17. WEIZMAN, R., GIL-AD, I., DICK, J., et al (1988) Low plasma immunoreactive β-endorphin levels in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 430-433.
18. ZELNIK, N., HERMAN, B. H., HAMMOCK, M. K., et al (1986) Role of opioid peptides in self-injurious behavior. Society for Neuroscience Abstracts, 12, 412.